Facebook
Twitter
LinkedIn
ForwardMiami Cancer Institute Global Summit on Immunotherapies for Hematologic Malignancies, Sixth Annual
Agenda
Friday, March 7 - 6.25 Cat. 1
| 7:30 - 8:45 a.m. | Registration, Breakfast and Visit Exhibits |
| 8:45 - 9:00 a.m. | Welcome and Introductions Guenther Koehne, M.D., Ph.D. |
| Multiple Myeloma | |
| 9:00 - 9:25 a.m. | From Doublets to Quadruple Combination Therapies for Newly Diagnosed Multiple Myeloma and Beyond: The Transformative Effect of Induction/Remission Therapy Followed by Maintenance in the Era of Novel Therapies Paul Richardson, M.D. |
| 9:25 - 9:50 a.m. | Update on T-cell Redirecting Therapies for Relapsed/Refractory Multiple Myeloma Adam Cohen, M.D. |
| 9:50 - 10:15 a.m. | Landscape of Multiple Myeloma Therapies in LATAM: Current Status and Unmet Needs Patricio Duarte, M.D. |
| 10:15 - 10:35 a.m. | Panel Discussion |
| 10:35 - 11:00 a.m. | Break and Exhibits |
| Non-Hodgkin Lymphoma | |
| 11:00 - 11:25 a.m. | Updates on Treatment Approaches in Diffuse Large B-Cell Lymphoma (DLBCL): Where Are We and Where Are We Heading? Matthew Matasar, M.D. |
| 11:25 - 11:50 a.m. | Positioning Transplantation and Cellular Therapies in the ‘Other’ B-NHLs (FL, MCL, CLL/SLL) Craig Sauter, M.D. |
| 11:50 - 12:15 p.m. | Update on Treatment Approaches for T-cell Lymphoma Steven M. Horwitz, M.D. |
| 12:15 - 12:35 p.m. | Panel Discussion |
| 12:35 - 1:05 p.m. | Lunch and Exhibits |
| 1:05 - 1:35 p.m. | Product Theater |
| Special Presentations | |
| 1:35 - 2:05 p.m. | Donor-derived Anti-viral Specific T Cells for Treatment of EBV PTLD and Refractory CMV Reactivation Guenther Koehne, M.D., Ph.D. |
| 2:05 - 2:35 p.m. | Strategies to Enhance Enrollment of Under-served Patients Onto Bone Marrow Transplant and Cellular Therapy Clinical Trials Juliet Barker, MBBS (Hons), FRACP |
| 2:35 - 2:55 p.m. | Break and Exhibits |
| Acute Myeloid Leukemia | |
| 2:55 - 3:20 p.m. | AML 2025: Therapeutic Integration of New Agents Richard Stone, M.D. |
| 3:20 - 3:45 p.m. | Targeted Therapies in Acute Myeloid Leukemia Eytan Stein, M.D. |
| 3:45 - 4:10 p.m. | Myelofibrosis: Current and Emerging Treatments Raajit Rampal, M.D. |
| 4:10 - 4:30 p.m. | Panel Discussion |
| 4:30 - 4:35 p.m. | Closing Remarks and Adjourn |
| 4:35 - 5:20 p.m. | Product Theater |
Saturday, March 8 - 3.75 Cat. 1
| 7:30 – 8:30 a.m. | Registration, Breakfast and Visit Exhibits |
| Novel Approaches to AML Therapies | |
| 8:30 – 8:50 a.m. | Antigen Specific T-cell Therapies - From Targeting Viruses to AML Catherine Bollard, M.D. |
| 8:50 – 9:10 a.m. | LYT-200, an Anti-Galectin-9 Antibody, for Treatment of AML/high-risk MDS Aleksandra Filipovic M.D. Ph.D. |
| 9:10 – 9:30 a.m. | Novel Approaches to Treat AML Relapse Post Allo SCT Guenther Koehne, M.D., Ph.D. |
| 9:30 – 9:50 a.m. | AI in Oncology TBD |
| 9:50 – 10:10 a.m. | Panel Discussion |
| 10:10 – 10:25 a.m. | Break and Visit Exhibits |
| 10:25 – 11:10 a.m. | Product Theater |
| Allogeneic Stem Cell Transplants | |
| 11:10 – 11:30 a.m. | Next Steps in Cancer Immunotherapy Marcel van den Brink, M.D., Ph.D. |
| 11:30 – 11:50 noon | Uncoupling GVL and GVH - Déjà Vu All Over Again? Robert Soiffer, M.D. |
| 11:50 – 12:20 p.m. | The Role of Haploidentical Transplants in 2025 Leo Luznik, M.D. |
| 12:20 – 12:40 p.m. | Novel Approaches to GVHD Prevention and Therapy Corey Cutler, M.D. |
| 12:40 – 1:10 p.m. | Panel Discussion |
| 1:10 – 1:15 p.m. | Closing Remarks and Adjourn |
NOTE: Schedule subject to change.
JW Marriott Miami
1109 Brickell Avenue
Miami, Florida 33131
United States
+1 (305) 329-3500
About the Venue
The JW Marriott Miami is located in the heart of Brickell, Miami's trendy destination for dining, shopping, and nightlife and is located a short walk away from the popular shopping and entertainment destination, Brickell City Centre. Guests are not far from all that Miami has to offer including the Perez Art Museum, Frost Science Museum, Kaseya Center (home of the Miami Heat), Adrienne Arsht Center, Port of Miami, South Beach, Coral Gables, Coconut Grove and Miami International Airport.
Rooms Rates and Highlights
- 24-hour room service - Free Wi-Fi for Marriott Bonvoy members - Complimentary fitness center access - Spa - Pool - Business Center
Travel Information
The drive time between the JW Marriott Miami and Miami International Airport (MIA) is around 20 minutes and covers a distance of around 8.2 miles.
Services + Amenities
Relax with a facial or full body massage by an expert therapist at Salus Spa. Afterward, continue to unwind in the warmth of the Miami sun at the JW Marriott Miami's stainless steel sky pool.
Adjacent to The Spa is our Fitness Studio, the perfect escape for an energizing workout, featuring state-of-art equipment and free weights.
Dining
Isabela's
With its natural light and views of Brickell Ave, Isabela's is the perfect place to start the day.
La Terraza Cafe & Bar
With its Plasma TV's and LED Screens tuned to popular sporting events & delicious casual fare served at lunch, dinner, and weekend Brunch makes La Terraza the ideal place to unwind with friends and family.
Downtown Miami and Brickell
Greater Miami is synonymous with beautiful beaches and towering palm trees - but in its urban center, it is the cityscape of glittering skyscrapers over Biscayne Bay that gets all the attention. Diverse, dynamic and densely populated, Downtown Miami and the adjoining Brickell area is a hub of international finance, dining, arts and entertainment that no visitor should miss.
| ⚠ | COVID-19 Protocols for All Attendees, Exhibitors and VendorsProof of COVID-19 vaccination or negative COVID-19 test is no longer required to attend a Baptist Health CME conference or symposium. Baptist Health's in-person COVID-19 policy is subject to change based on COVID-19 community levels and any updated guidance from CDC and/or federal or state officials in localities hosting a Baptist Health in-person meeting or event. Baptist Health reserves the right to modify its COVID-19 related procedures and health screening protocols in its sole discretion at any time. Participants will be informed of any such changes on an ongoing basis. Masks are welcome but not required. Please understand and respect that wearing a mask is a personal and individual choice of your fellow conference attendees. Masks will made available for attendees onsite at conferences upon request. |
Symposium Director
Deputy Director
Chief, Blood and Marrow Transplant and Hematologic Oncology
Miami Cancer Institute
Miami, Florida
Faculty
Hematology/Oncology
Bone Marrow Transplant and Cellular Therapy Program
Weill Cornell Medicine
New York, New York
Director, Center for Cancer and Immunology
Director, Program for Cell Enhancement and Technologies for Immunotherapy
Interim Chair, Department of Pediatrics
Interim Director, Children's National Research Institute
Interim Executive Vice President & Chief Academic Officer
Children's National Hospital
Washington, D.C.
Associate Professor of Medicine
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania
Medical Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts
Associate Professor of Hematology
Instituto Universitario CEMIC
Bueno Aires, Argentina
Department of Surgery and Cancer
Imperial College of London
London, England
Lymphoma Specialist and Cellular Therapist
Memorial Sloan Kettering Cancer Center
New York, New York
Section Chief
Baylor College of Medicine
Houston, Texas
Chief, Division of Blood Disorders
Rutgers CINJ and RWJBarnabas Health
Professor of Medicine, Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey
Professor of Medicine
Columbia University Irving Medical Center
New York, New York
Associate Member
Clinical Director
Leukemia Service
Memorial Sloan Kettering Cancer Center
New York, New York
Clinical Program Leader and Director of Clinical Research
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
RJ Corman Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Hematology and Medical Oncology
Director, Blood and Marrow Transplant Program
Cleveland Clinic Main Campus
Cleveland, Ohio
Chief, Division of Hematologic Malignancies
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Assistant Attending Physician
Director, Program for Drug Development in Leukemia
Leukemia Service, Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York
Chief of Staff, Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
President of City of Hope Los Angeles
National Medical Center
Los Angeles, California
NOTE: Faculty subject to change.
Disclosures and Resolution of Conflicts of InterestDisclosure Policy and Disclaimer
Accreditation
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 10 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for a total of 10 credit hours, CE Broker Course #20-1283702, Day 1 - 6.25 credits, CE Broker Course #20-1283704, Day 2 - 3.75 credits, by the Florida Boards of Medicine, Osteopathic Medicine and by the Florida Council of Physician Assistants.
This activity is approved for 10 credit hours for Nurse Practitioners, Nurses, Laboratory Personnel and Respiratory Therapists. CE Broker Course #20-1283702, Day 1 - 6 credits, CE Broker Course #20-1283704, Day 2 - 4 credits. Baptist Health South Florida CE Broker Provider #50-182.
This activity has been approved for a total of 10 credit hours for Pharmacists and Techs, CE Broker Course #20-1283702, Day 1 - 6.25 credits, CE Broker Course #20-1283704, Day 2 - 3.75 credits. Baptist Health South Florida CE Broker Provider #50-182.
The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.
AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Disclaimer
Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.
While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use.
Available Credit
- 10.00 AMA PRA Category 1 Credit™
- 10.00 General certificate of attendance
- 10.00 Florida Board of Laboratory Personnel
- 10.00 Nurse Practitioners
- 10.00 Florida Board of Nursing
- 10.00 Florida Board of Pharmacy
- 10.00 Florida Board of Respiratory Therapy
We gratefully acknowledge the following exhibitors:
AbbVie
AbbVie Pharmacyclics
Adaptive Biotechnologies
ADC Therapeutics
Agios Pharmaceuticals
Amgen Oncology Rare Disease
Astellas Pharmaceuticals
AstraZeneca - Hematology
Azurity Pharmaceuticals
Beigene
Blueprint Medicines
Bristol-Myers Squibb
Daiichi Sankyo
Gallop Oncology
Genentech
Genmab
Gift of Life Marrow Registry
GlaxoSmithKline
Incyte
Janssen Biotech
Jazz Pharmaceuticals
Karius Diagnostics
Kite Pharma
Kyowa Kirin
Merck
Miami Cancer Institute
Novartis
Omeros Pharma
Pharmaessentia
Recordati Rare Diseases
Rigel Pharmaceuticals
Sanofi Genzyme
Sanofi-Kadmon
Sanofi Rare Blood Disorders
Sellas Life Sciences
Sobi
Sumitomo Pharma
Takeda Oncology
We welcome the following companies as first-time exhibitors:
Gamida Cell
Geron
Syndax Pharmaceuticals